e-Learning | Management of Polycythaemia Vera

6th June 2019 by Louise Hudman

e-Learning | Management of Polycythaemia Vera

This is an updated guideline on the diagnosis and management of polycythaemia vera (PV) from the British Society for Haematology. It was published in Nov 18. PV is the same as polycythaemia rubra vera and PCV.

Much of this is beyond what we need, but it outlines how we should be approaching a patient with raised haematocrit, which is useful.

If (like me) your understanding of PV is a bit sketchy, then patient.co.uk has a good reminder. In short, PV is a clonal haematological malignancy. It is caused by a mutation in a single haematopoietic stem cell. The JAK2 gene is mutated in nearly all PV.

What should trigger us to investigate further?

Read for free

Sign up to access everything.

Free trial

Login

Already a member? Login to view this content.

Login

Related content

"I started working as a locum GP in January this year and NASGP have been invaluable in helping to co-ordinate my bookings and organise all the administrative aspects of sessional work which can be complex and time consuming. Their client support is outstanding and they have always resolved any queries promptly and personally. They care about the service they provide and I would not hesitate to recommend them to any sessional GPs who want to minimise time spent on administration and focus on providing patients with high quality care."

Dr Paul Riley, Locum GP

Dr Paul Riley, Locum GP

See the full list of features within our NASGP membership plans

Membership